CRTO
Criteo S.A.
CRTO offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
META
Meta Platforms, Inc.
META has the edge over CRTO overall, supported by stronger modeled upside and stronger fundamentals.
CRTO Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Unavailable |
CRTO's cash flow is currently healthy, and its profitability is stable, but its revenue is under pressure. There isn't enough data to rate its balance sheet.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CRTO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.9x | $17.43 | — |
| Cheap | 8.6x | $11.90 | -32% |
| Current | 13x | $17.43 | — |
| Fair | 19x | $26.52 | +52% |
| Expensive | 33x | $45.77 | +163% |
Historical ranges are pointers, not guarantees.
CRTO's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 4.9x next year's earnings, in its cheap range.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META has the edge over CRTO in the historical PE scenario, which offers more potential upside but is not a forecast.
CRTO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CRTO's earnings to grow and its profitability to improve, with its revenue holding steady.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
CRTO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.59 | +160% |
| Q3 2026 | $1.38 | -53% |
| Q2 2026 | $1.97 | -17% |
| Q1 2026 | $2.14 | -12% |
| Q4 2025 | $2.65 | +39% |
| Q3 2025 | $2.96 | +74% |
| Q2 2025 | $2.37 | +39% |
| Q1 2025 | $2.44 | +103% |
| Q4 2024 | $1.90 | +116% |
CRTO's earnings per share have fallen from their peak: $1.38 over the past year, against $2.96 in late 2025.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META earned $29.32 per share over the past year, up 30% from the year before.
CRTO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $416.5M | -11% |
| Q2 2026 | $428M | -11% |
| Q1 2026 | $424.6M | -5.9% |
| Q4 2025 | $541.1M | -2.2% |
| Q3 2025 | $469.7M | +2.3% |
| Q2 2025 | $482.7M | +2.4% |
| Q1 2025 | $451.4M | +0.3% |
| Q4 2024 | $553M | -2.3% |
CRTO's revenue has slid since its 2020 peak: $416M last quarter, down 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5% | -6 points |
| Q2 2026 | 3.5% | -2.8 points |
| Q1 2026 | 2.5% | -8.2 points |
| Q4 2025 | 13% | -3.7 points |
| Q3 2025 | 11% | +8.9 points |
| Q2 2025 | 6.3% | -1.5 points |
| Q1 2025 | 11% | +8.4 points |
| Q4 2024 | 17% | +1.5 points |
CRTO's operating margin was 5% last quarter, down 6 points from the same quarter a year ago.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over CRTO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over CRTO on profitability, with a higher operating margin.
CRTO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.1M | -68% |
| Q2 2026 | -$37.9M | -$1.3M |
| Q1 2026 | $15.4M | -66% |
| Q3 2025 | $66.6M | +16% |
| Q2 2025 | -$36.6M | -313% |
| Q1 2025 | $45.3M | +223% |
| Q3 2024 | $57.5M | +193% |
| Q2 2024 | $17.2M | +1194% |
CRTO still generates free cash flow, though less than at its 2023 peak: $132M over the past year.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
CRTO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -751K shares |
| 1 year | -10% | -5.6M shares |
| 3 years | -17% | -10.4M shares |
| 5 years | -22% | -14.4M shares |
| Available history | -24% | -15.8M shares |
CRTO has the edge over META on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.1M |
| Q2 2026 | $30.4M |
| Q1 2026 | $31M |
| Q4 2025 | $36.6M |
| Q3 2025 | $10.9M |
| Q2 2025 | $48.3M |
| Q1 2025 | $56.2M |
| Q4 2024 | $67.1M |
CRTO spent $102M buying back its own shares over the past year, down 44% from the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
CRTO Net Leverage
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
CRTO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.3 | Neutral |
| Stochastic | 31.1 | Neutral |
CRTO's weekly RSI is 50 (neutral) and its Stochastic is 31 (neutral).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
CRTO PE vs Communication Services Sector
| Metric | CRTO | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 16x | 23% below |
| PE % | 39 | 26 | 13 pts above |
CRTO has the edge over META on valuation relative to its sector.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
CRTO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.6 | 12% above |
| 20 week MA | $17.8 | 1.9% below |
| 50 week MA | $18.3 | 4.5% below |
| 100 week MA | $23.5 | 26% below |
| 200 week MA | $28.7 | 39% below |
CRTO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 39% below its 200-week average.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
CRTO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.2 | $20.8 | +21% |
| 2021 | $20.8 | $37.1 | +78% |
| 2022 | $37.1 | $26.0 | -30% |
| 2023 | $26.0 | $25.3 | -2.5% |
| 2024 | $25.3 | $40.5 | +60% |
| 2025 | $40.5 | $20.0 | -51% |
| 2026 YTD | $20.0 | $17.4 | -13% |
CRTO has finished lower in three of the last six years. It's down 13% so far in 2026.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over CRTO on returns for 2026, with the stronger performance.